Breast cancer researchers in Britain have come up with a new classification system for the...
The potentially deadly amoeba threatens thousands of people in Saint John the Baptist Parish....
Insurers can no longer reject customers with expensive medical conditions thanks to the health care overhaul, but there's still wiggle room for them to discourage the sickest and costliest patients from enrolling.
Introducing a stainless steel version of the WLC60 heavy-duty LED lights, designed for use in extremely harsh conditions.
A third top doctor has died from Ebola in Sierra Leone, a government official said Wednesday, as health workers tried to determine how a fourth scientist also contracted the disease before being evacuated to Europe.
A Mississippi man has invented a device that prevents pills from spilling out of bottles, where kids may find and eat them from the floor.
Undercover Colors, a nail polish with the ability to detect certain date rape drugs, is aiming to help fight the widespread problem of sexual assaults in college communities.
"Do-it-yourself" blood pressure measurements and medicine changes work better than usual doctor-office care in some patients, a study of older adults in England found. Those who did their own readings at home and adjusted their medicine as needed had healthier blood pressure levels after a year than those who got standard doctors' care.
Tris Pharma Selected as an Award Winner in the New Jersey Business & Industry Association's 2014 Awards for ExcellenceAugust 27, 2014 8:16 am | News | Comments
Tris Pharma, a specialty pharmaceutical company focused on developing innovative drug delivery technologies, today announced that it has been selected as an award winner in the New Jersey Business & Industry Association's 2014 Awards for Excellence competition in the Business Expansion category.
In recent years genetic testing has been introduced. It has caused a bit of for and against uproar. Information from this testing could be used for changing the lifestyle that could avert diseases one might encounter with age or even could be used for personalized medicine. Better lifestyle could lower pharma sales and an unacceptable scenario by the current players.
The Veterans Affairs Department says investigators have found no proof that delays in care caused any deaths at a VA hospital in Phoenix, deflating an explosive allegation that helped expose a troubled health care system in which veterans waited months for appointments while employees falsified records to cover up the delays.
An Oklahoma oral surgeon whose filthy clinic conditions led to the testing of thousands of patients for HIV and hepatitis permanently surrendered his professional license on Friday. Scott Harrington's two Tulsa-area clinics have been closed since March 2013, when state health officials urged about 7,000 of his current and former patients to get tested for the diseases.
Taxes? Who wants to think about taxes around Labor Day? But if you count on your tax refund and you're one of the millions getting tax credits to help pay health insurance premiums under President Barack Obama's law, it's not too early.
NeuroSigma today announced that the U.S. Department of the Army, through the U.S. Army Medical Research and Material Command, has funded a Phase II clinical trial at the University of California, Los Angeles, that will examine the use of external trigeminal nerve stimulation (eTNS) as treatment for post-traumatic stress disorder (PTSD).
Two American aid workers have recovered from Ebola and left an Atlanta hospital, after weeks of intensive treatment in a special isolation unit. They were first two Ebola patients ever brought to the United States...
Mallinckrodt plc announced the appointment of a new Senior Vice President and President of the Company’s Autoimmune and Rare Disease business, as well as a new Senior Vice President and the Chief Compliance Officer at Mallinckrodt. The appointments are effective immediately.
New research suggests a one-two punch could help battle polio in some of the world's most remote and strife-torn regions: Giving a single vaccine shot to children who've already swallowed drops of an oral polio vaccine greatly boosted their immunity.
The federal government is finalizing new restrictions on hundreds of medicines containing hydrocodone, the highly addictive painkiller that has grown into the most widely prescribed drug in the U.S.
Researchers have pinpointed the environmental source of fungal infections that have been sickening HIV/AIDS patients in Southern California for decades. It literally grows on trees.
Bristol-Myers Squibb Company and Pfizer Inc. announced the U.S. Food and Drug Administration (FDA) has approved a Supplemental New Drug Application for Eliquis for the treatment of DVT and PE, and for the reduction in the risk of recurrent DVT and PE following initial therapy.
Biogen Idec (NASDAQ: BIIB) announced the appointment of Adriana (Andi) Karaboutis as executive vice president, Technology and Business Solutions, effective September 24, 2014.
As part of a continuing mission to improve global health, the U.S. Pharmacopeial Convention (USP) has joined with the Alliance for Safe Online Pharmacies (ASOP) to combat the threat posed by the illegal online sale of medicines.
AstraZeneca announced that it has entered into a collaboration with gene sequencing company Illumina, Inc. to develop its next generation sequencing (NGS) platform for companion diagnostic tests applicable across AstraZeneca’s oncology portfolio.
Covidien plc announced that the U.S. Food and Drug Administration has approved changes to the manufacturing process for the polytetrafluoroethylene (PTFE) coating on the delivery wire of the company’s Pipeline™ embolization device.
Health care company Baxter International has announced plans for a multimillion expansion of its manufacturing plant in Opelika, Ala.
Recent research from shows that insulin, which is normally released from the beta cells of the pancreas, prevents the toxic effects of alcohol and fatty acid metabolites.
Finnish researchers have found that the low-expression variant of fatty acid-binding protein 4 (FABP4), which is particularly common among Finns, reduces the risk of heart attack and stroke. The finding revealed a promising new way to customise a potentially preventive drug for atherosclerosis.
- Page 1